NR4A1 and pulmonary arterial hypertension: In patients with pulmonary arterial hypertension (PAH), the pulmonary artery smooth muscle cells (PASMCs) exhibited increased proliferation and survival and decreased expression of NR4A1, NR4A2, and NR4A3 (protein and mRNA) compared to normal lung PASMCs [93].